| Date Filed | Type | Description |
| 06/08/2023 |
4
| Nagendran Sukumar (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 9,650 options to buy
@ $6.37, valued at
$61.5k
|
|
| 05/18/2023 |
4
| Nagendran Sukumar (President and Head of R&D) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Bought 5,000 shares
@ $0.68, valued at
$3.4k
|
|
| 01/04/2023 |
4
| Nagendran Sukumar (President and Head of R&D) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Granted 790,093 options to buy
@ $2.26, valued at
$1.8M
|
|
| 12/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Nagendran Sukumar (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 51,000 options to buy
@ $0.625, valued at
$31.9k
|
|
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/23/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/29/2019 |
4
| Nagendran Sukumar (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 32,258 shares
@ $4.65, valued at
$150k
|
|
| 06/14/2019 |
4
| Nagendran Sukumar (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 10,000 options to buy
@ $5.26, valued at
$52.6k
|
|
| 05/09/2019 |
3
| Nagendran Sukumar (Director) has filed a Form 3 on Health Sciences Acquisitions Corp |
| 12/17/2018 |
4
| Nagendran Sukumar (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 17,240 options to buy
@ $23.58, valued at
$406.5k
|
|
| 09/13/2018 |
4
| Nagendran Sukumar (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 2,760 options to buy
@ $50.65, valued at
$139.8k
|
|
| 09/13/2018 |
3
| Nagendran Sukumar (Director) has filed a Form 3 on Solid Biosciences Inc. |
| 05/15/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2018 |
4
| Nagendran Sukumar (Sr. VP & Chief Medical Officer) has filed a Form 4 on AveXis, Inc.|
Txns:
| Granted 3,800 shares
@ $0
Granted 15,000 options to buy
@ $133.8, valued at
$2M
|
|
| 03/05/2018 |
4
| Nagendran Sukumar (Sr. VP & Chief Medical Officer) has filed a Form 4 on AveXis, Inc.|
Txns:
| Exercised 1,780 shares
@ $18.47, valued at
$32.9k
Sold 74 shares
@ $121.51, valued at
$9k
Sold 120 shares
@ $123.16, valued at
$14.8k
Sold 175 shares
@ $124.29, valued at
$21.8k
Sold 449 shares
@ $125.72, valued at
$56.4k
Sold 504 shares
@ $126.95, valued at
$64k
Sold 408 shares
@ $127.99, valued at
$52.2k
Sold 50 shares
@ $128.91, valued at
$6.4k
Exercised 1,780 options to buy
@ $18.47, valued at
$32.9k
|
|
| 02/05/2018 |
4
| Nagendran Sukumar (Sr. VP & Chief Medical Officer) has filed a Form 4 on AveXis, Inc.|
Txns:
| Sold 1,001 shares
@ $117.12, valued at
$117.2k
Sold 501 shares
@ $118.01, valued at
$59.1k
Sold 3 shares
@ $118.96, valued at
$356.9
Sold 258 shares
@ $120.79, valued at
$31.2k
Sold 17 shares
@ $122.83, valued at
$2.1k
Exercised 1,780 options to buy
@ $18.47, valued at
$32.9k
|
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2017 |
4
| Nagendran Sukumar (Sr. VP & Chief Medical Officer) has filed a Form 4 on AveXis, Inc.|
Txns:
| Sold 318 shares
@ $93.72, valued at
$29.8k
Sold 1,327 shares
@ $94.92, valued at
$126k
Sold 135 shares
@ $95.81, valued at
$12.9k
Exercised 1,780 options to buy
@ $18.47, valued at
$32.9k
|
|
| 11/03/2017 |
4
| Nagendran Sukumar (Sr. VP & Chief Medical Officer) has filed a Form 4 on AveXis, Inc.|
Txns:
| Sold 252 shares
@ $98.51, valued at
$24.8k
Sold 431 shares
@ $100.05, valued at
$43.1k
Sold 631 shares
@ $100.7, valued at
$63.5k
Sold 42 shares
@ $102, valued at
$4.3k
Sold 149 shares
@ $104.06, valued at
$15.5k
Sold 205 shares
@ $105.02, valued at
$21.5k
Sold 70 shares
@ $106.26, valued at
$7.4k
Exercised 1,780 options to buy
@ $18.47, valued at
$32.9k
|
|
| 10/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/12/2017 |
4
| Nagendran Sukumar (Sr. VP & Chief Medical Officer) has filed a Form 4 on AveXis, Inc.|
Txns:
| Granted 25,200 options to buy
@ $77.24, valued at
$1.9M
|
|
| 05/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/05/2017 |
4
| Nagendran Sukumar (Sr. VP & Chief Medical Officer) has filed a Form 4 on AveXis, Inc.|
Txns:
| Sold 1,781 shares
@ $76.13, valued at
$135.6k
Exercised 1,781 options to buy
@ $18.47, valued at
$32.9k
|
|
|